Olga A. Partington, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Olga has substantial experience in inter partes review proceedings. In addition, she has been involved in several other contested proceedings before the USPTO, such as inter partes re-examinations and interferences.

Olga also has extensive experience in drafting patentability, infringement, and validity opinions, and in working with technical experts. She also has experience in assisting clients in designing around patents, and has been involved in pharmaceutical patent litigations brought under the Hatch-Waxman Act. Her practice also includes domestic and foreign patent prosecution, particularly chemical patents. She also has experience in counseling clients on patentability strategies.

Olga gained extensive technical experience in the areas of nucleic acid chemistry, organic, bioinorganic, and biological chemistry, enzymology, and spectroscopy in the laboratories of Dr. Sheila David and Nobel Prize laureate Dr. Paul Modrich. She earned her J.D. from The Catholic University of America Columbus School of Law, her Ph.D. and her B.S. in chemistry from the University of Utah.

Technical Publications

  • Engstrom LM, Partington OA, David SS. Biochemistry.2012 Jun 26;51(25):5187-97. Epub 2012 Jun 12. “An Iron-Sulfur Cluster Loop Motif in the Archaeoglobus fulgidus Uracil-DNA Glycosylase Mediates Efficient Uracil Recognition and Removal.”
  • Pluciennik A, Burdett V, Lukianova O, O’Donnell M, Modrich P. J Biol Chem. 2009 Nov 20;284(47):32782-91. Epub 2009 Sep 25. “Involvement of the beta clamp in methyl-directed mismatch repair in vitro.”
  • Kadyrov FA, Holmes SF, Arana ME, Lukianova OA, O’Donnell M, Kunkel TA, Modrich P. J Biol Chem. 2007 Dec 21;282(51):37181-90. Epub 2007 Oct 19.”Saccharomyces cerevisiae MutLalpha is a mismatch repair endonuclease.”
  • Boal, A.K., Yavin, E., Lukianova, O.A., O’Shea, V.L., David, S.S., Barton, J.K., “DNA- Bound Redox Activity of DNA Repair Glycosylases Containing [4Fe-4S] Clusters” (2005) Biochemistry, 44(23); 8397- 8407
  • Lukianova, O.A., David, S.S., “A Role for [4Fe- 4S] Clusters in DNA Repair”, (2005) Curr. Opin. Chem. Biol.,9(2); 145-151.
  • Chepanoske, C. L., Lukianova, O. A., Lombard, M., Golinelli-Cohen, M.-P., and David, S. S., “A Residue in MutY Important for Catalysis Identified by Photocross- Linking and Mass Spectrometry” (2004) Biochemistry, 43(3); 651-662

  • J.D., The Catholic University of America Columbus School of Law
  • Ph.D., Chemistry, University of Utah
  • B.S., Chemistry, University of Utah

  • District of Columbia
  • United States Patent & Trademark Office
  • Utah

  • American Chemical Society

  • Russian
  • Ukrainian

Speaking Engagement

Limitations of Patent Owner’s Rights: How to Navigate Legal Challenges and Balance Patent Owner’s Rights in Today’s Political Climate

Westlake Village, CA, Four Seasons Hotel, December 5, 2023 9:30 AM - 10:20 AM PST

Speaking Engagement

2023 Focus on Pharma

Washington, DC, April 14, 2023 8:30 AM - 6:00 PM PST

Speaking Engagement

Protecting and Defending Inventions in the Microbiome Space: Challenges and Strategies

Virtual, December 1, 2020 9:15 AM - 9:45 AM PST

Speaking Engagement

Protecting and Defending Inventions in the Microbiome Space: Challenges and Strategies

Virtual, November 6, 2020 4:30 PM - 5:00 PM PST

Speaking Engagement

Microbiome R&D and Business Collaboration Forum: USA

San Diego, CA, Paradise Point Resort and Spa, October 29, 2018 12:00 AM - 11:59 PM PST

Related Resources

From Olga A. Partington, Ph.D.

In the News

November 27, 2023

PTAB Denies Review Of Univ. Of Texas System Cancer Patent

Law360

Firm Announcements

November 27, 2023

Sterne Kessler Secures Denial of PGR for Largest Cancer Center in the US

Sterne, Kessler, Goldstein & Fox

In the News

May 17, 2023

Law360 Names Attys Who Moved Up The Firm Ranks In Q1

Law360

Press Release

January 4, 2023

Sterne Kessler Elects Record-High Seven Directors in 2023

Sterne, Kessler, Goldstein & Fox

In the News

March 14, 2022

Almirall Loses Appeal on Acne Treatment Patent at Fed. Cir.

Bloomberg Law

In the News

March 14, 2022

Fed. Circ. Affirms PTAB's Ax of Acne Drug Patent

Law360

Reports

March 7, 2022

2021 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

March 7, 2022

Is the Tide Turning on Chemical Patent Challenges at the PTAB?

Sterne, Kessler, Goldstein & Fox Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

Press Release

March 7, 2022

Sterne Kessler Publishes 2021 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

In the News

April 26, 2021

Good bacteria: The microbiome, its vast therapeutic potential, and the challenges ahead

STAT Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

In the News

April 1, 2020

PTAB Upholds 3 Teva Migraine Patents Challenged By Eli Lilly

Law360 Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

Press Release

January 2, 2020

Sterne Kessler Elects Three New Directors and Promotes Five Attorneys to Counsel

Sterne, Kessler, Goldstein & Fox P.L.L.C. Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

In the News

November 21, 2019

Teva Gets PTAB To Review Cushing's Syndrome Drug Patent

Law360 Deborah Sterling, Ph.D., Olga A. Partington, Ph.D.

PTAB Strategies and Insights

December 21, 2017

Perspectives on the PTAB Newsletter - December 2017

Multiple Authors

Bylined Articles

December 21, 2017

The Turning Tide of Adoption of the Lead Compound Analysis Is Favoring Patent Owners at the PTAB

Sterne, Kessler, Goldstein & Fox Jason D. Eisenberg, Olga A. Partington, Ph.D.

Global Patent Prosecution

June 15, 2017

Global Patent Prosecution Newsletter - June 2017

Multiple Authors

Bylined Articles

June 15, 2017

A Comparison of US and EPO Post Grant Practices

Sterne, Kessler, Goldstein & Fox Olga A. Partington, Ph.D., Paul A. Calvo, Ph.D.

Client Alert

January 11, 2017

Federal Circuit Dismisses IPR Appeal for Lack of Standing

Multiple Authors

In the News

October 29, 2015

ImmunoGen Cancer Patent Still Valid After Phigenix's Dispute

Bloomberg BNA Multiple Authors

In the News

October 28, 2015

PTAB Upholds ImmunoGen’s Breast Cancer Drug Patent

Law360 Multiple Authors

Bylined Articles

March 24, 2015

On the Attack

European Biopharmaceutical Review Paul A. Calvo, Ph.D., Olga A. Partington, Ph.D.

Bylined Articles

December 1, 2014

Patent Prosecution in the Era of IPR

European Biotechnology News Paul A. Calvo, Ph.D., Olga A. Partington, Ph.D.